Psilocybin Tied to Fewer Symptoms With Major Depressive Disorder
TUESDAY, Sept. 5, 2023 (HealthDay News) -- Psilocybin treatment is associated with a clinically significant sustained reduction in depressive symptoms and functional disability in individuals with major depressive disorder (MDD), according to a phase 2 study published online Aug. 31 in the Journal of the American Medical Association.
Charles L. Raison, M.D., from Usona Institute in Fitchburg, Wisconsin, and colleagues evaluated the magnitude, timing, and durability of antidepressant effects and safety of a single dose of psilocybin in patients with MDD. The analysis included 104 adults (aged 21 to 65 years) with MDD who were randomly assigned (1:1) to receive a single dose of psilocybin or niacin placebo.
The researchers found that psilocybin treatment was associated with significantly reduced Montgomery-Asberg Depression Rating Scale scores versus niacin from baseline to day 43 (mean difference, −12.3; P < 0.001) and from baseline to day 8 (mean difference, −12.0; P < 0.001). There was also a significant reduction in Sheehan Disability Scale scores for psilocybin treatment compared with niacin (mean difference, −2.31; P < 0.001) from baseline to day 43. Compared with niacin treatment, more participants receiving psilocybin had sustained response (but not remission). Psilocybin treatment was associated with a higher rate of overall adverse events (AEs) and a higher rate of severe AEs, but there were no serious treatment-emergent AEs.
“These findings add to increasing evidence that psilocybin -- when administered with psychological support -- may hold promise as a novel intervention for MDD,” the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Related Posts
Pfizer Plans to Charge More Than $100 Per COVID-19 Shot in 2023
MONDAY, Oct. 24, 2022 (HealthDay News) -- Some Americans could pay up to $130 to...
Moderna Begins Testing Booster Shot Aimed at Omicron
THURSDAY, Jan. 27, 2022 (HealthDay News) -- Moderna Inc. announced Wednesday...
Ovary Removal Before Menopause Could Raise a Woman’s Odds for Parkinson’s
TUESDAY, Nov. 8, 2022 (HealthDay News) -- Women who have both ovaries removed...
Study Finds Good Long-Term Outcomes for Appendicitis Treated Without Surgery
THURSDAY, Aug. 10, 2023 (HealthDay News) -- Most people with appendicitis who...